-
Description
-
Why Us?
Antigenic drifts (minor changes) of seasonal influenza viruses will lead to emergence of new strains. New strains appear from time to time and at irregular intervals. This explains why the World Health Organization will make recommendations on the formulation of influenza vaccine every year.
Seasonal influenza is different from influenza pandemic. The occurrence of influenza pandemic results from the emergence of a pandemic strain, which appears when antigenic shift (major change) occurs in a novel influenza virus resulting in efficient human-to-human transmission. People will have very little or no immunity to the virus, which causes the virus to spread more rapidly and extensively than a seasonal influenza virus.
Seasonal influenza vaccination
The vaccine is safe and effective in preventing seasonal influenza and its complications.
Influenza can cause serious illnesses in high-risk individuals and even healthy persons. Given that seasonal influenza vaccines are safe and effective, all persons aged 6 months or above except those with known contraindications are recommended to receive influenza vaccine for personal protection.
Usually, it is suggested that vaccination should be received in autumn every year. About 2 weeks after vaccination, the body will develop a sufficient level of antibodies to protect against influenza virus infection.
Purchase Remark: Must be prescribed and injected by doctors.
Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.
VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.
MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.
CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity